We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Inks Deal to Develop Its First Follow-On Biologic; More on the Way
Barr Inks Deal to Develop Its First Follow-On Biologic; More on the Way
March 31, 2005
Barr Laboratories is taking the plunge into the follow-on biologics market, announcing March 30 that it is partnering with Croatian biopharmaceutical firm PLIVA to develop its first biogeneric product.